The Prospects for an IP Waiver Under the TRIPS Agreement
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
The Prospects for an IP Waiver Under the TRIPS Agreement

Author
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.

Having a PhD and specialized in biomedical innovation law & legal/regulatory issues in biologic drug development? Interested in empirical legal research and data analysis?Then join our international research collaboration at the University of Copenhagen with core…
Looking forward to hear Professor Peter Lee’s (UC Davis) talk on “Innovation and the Firm: Vertical Integration in Patent-Intensive Industries” at the University of Copenhagen on Friday, Friday, September 8th 2017 from 10:00 – 12:00. If…
By Timo Minssen Dear readers and colleagues, I would like to take this opportunity to wish you all a very happy, healthy and peaceful year 2016. Reaching the end of 2015, I cannot stop thinking about…
By Timo Minssen I have now left Harvard Law School and returned to Europe and commenced my work with IPRs and “biobanking” as a visiting research fellow at the University of Oxford. I remember the…
By Timo Minssen Please find attached a ppt presentation on “New regulatory pathways and incentives for sustainable antibiotics: Recent European & US Initiatives” given on March 7, 2014 at the Broad Institute of MIT and Harvard.…
The Europäische Akademie GmbH – a research institution of the Federal State of Rhineland-Palatinate and the German Aerospace Center (DLR) – is currently inviting applications for the international summer school: “Analyzing the societal dimensions of…